Preventive efficacy of six monthly doses of NexGard® PLUS or Simparica Trio® against a macrocyclic lactone-resistant isolate (JYD-34) of Dirofilaria immitis and of a single dose of NexGard PLUS against a susceptible isolate.

Autor: Prullage J; Boehringer Ingelheim Animal Health, Missouri Research Center, 6498 Jade Rd., Fulton, MO, 65251, USA. joseph.prullage@boehringer-ingelheim.com., Frost J; Boehringer Ingelheim Animal Health, Georgia Research Center, 1730 Olympic Dr., Athens, GA, 30601, USA., DiCosty U; TRS Labs, Inc., 215 Paradise Boulevard, Athens, GA, 30607, USA., Martin E; Boehringer Ingelheim Animal Health, Georgia Research Center, 1730 Olympic Dr., Athens, GA, 30601, USA., Dumont P; Boehringer Ingelheim Animal Health, Georgia Research Center, 1730 Olympic Dr., Athens, GA, 30601, USA., Yoon S; Boehringer Ingelheim Animal Health, Georgia Research Center, 1730 Olympic Dr., Athens, GA, 30601, USA., Süssenberger R; Boehringer Ingelheim Vetmedica GmbH, Binger Str. 173, 55216, Ingelheim am Rhein, Germany.

Publikováno v: Parasites & vectors [Parasit Vectors] 2024 Dec 18; Vol. 17 (1), pp. 519. Date of Electronic Publication: 2024 Dec 18.